Global Cannabis Executes First Stage of Vertical Integration Strategy for EU and Israeli Medical Cannabis Markets

VANCOUVER, BC / ACCESSWIRE / May 13, 2019 / Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a

Read more

Featured Interview: CEO Robert Goldstein of US Nuclear Corp. (OTCPink: UCLE)

CEO Robert Goldstein of US Nuclear Corp., talks about recent agreement with Magneto Internal Fusion, the need for new electric power plants, and building plants with less emissions.

Read more

Applied Biosciences Hires Former Pfizer Business Unit Chief Medical Officer as Chief Executive Officer

LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid-based therapeutics company focused on

Read more

Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2018 Financial Results and Provide Business Update

Conference Call Scheduled for Thursday, April 25th at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / April 24, 2019 /

Read more

US Nuclear Signs Agreement to Acquire an Interest in a Leading Fusion Power Developer and Rights to Manufacture and Sell Fusion Power Generators for the Electric Power Grid

Los Angeles, CA, April 23, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — US Nuclear Corp. (OTC-UCLE) and Magneto-Inertial Fusion Technologies,

Read more

GSRX Industries Inc. Signs Lease in Palm Springs for Second California Adult-Use and Medicinal Cannabis Dispensary

DORADO, Puerto Rico, April 17, 2019 (GLOBE NEWSWIRE) — GSRX Industries Inc. (OTCQB: GSRX) (“GSRX” or the “Company”) announced today

Read more

Featured Interview: CEO Robert Davidson of CURE Pharmaceutical Holding Corp. (OTCQB: CURR)

CEO Robert Davidson of CURE Pharmaceutical Holding Corp., talks about licenses granted to them, working towards precise dosing, and navigating the ever changing regulatory guidelines.

Read more

Featured Interview: CEO Robert Goldstein of US Nuclear Corp. (OTCPink: UCLE)

CEO Robert Goldstein of US Nuclear Corp., discusses recent addition of Chemical, Bacterial, and Viral Detection to DroneRAD systems, the market for them, and the continuing need for medical isotopes.

Read more